robert_castaigne_sanofi

Sanofi names audit committee chairman

pharmafile | March 10, 2015 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Robert Castaigne, Sanofi 

Sanofi has looked to its own board to fulfil the role of chairman as it names Robert Castaigne chairman of the firm’s audit committee. 

Castaigne succeeds Dr Klaus Pohle who held this position since 2004, and who will now still remain as a member of the board of directors at the French company. 

Castaigne has held various positions at the Total group including chief financial officer, and was a member of its executive committee. He has been a member on the Sanofi board since 2000, and of its audit committee since 2008.

Advertisement

Serge Weinberg, chairman and chief executive of Sanofi, says: “I thank Dr Pohle for his 11 years of dedicated service as Sanofi’s audit committee chairman. Mr Castaigne’s appointment as chairman continues Sanofi’s commitment to a strong and engaged audit committee.”

Related Content

Sanofi and Regeneron’s Dupixent receives CHMP recommendation for chronic spontaneous urticaria

Sanofi and Regeneron have received a positive opinion from the European Medicines Agency’s (EMA) Committee …

Sanofi’s treatment granted orphan designation for rare chronic inflammatory condition

The European Medicines Agency has granted orphan designation to Sanofi’s investigational Bruton’s tyrosine kinase (BTK) …

sanofi

Sanofi completes acquisition of Vigil Neuroscience to early neurology pipeline

Sanofi has announced that it has finalised its acquisition of Vigil Neuroscience, a US-based biotechnology …

The Gateway to Local Adoption Series

Latest content